Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Wraith

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Immunology Series|January 1, 1993
Autoantigenic peptide therapy in experimental autoimmune encephalomyelitisD C Wraith
British Journal of Rheumatology|January 1, 1991
The use of class II MHC binding peptides in immunotherapyD C Wraith
Clinical and Experimental Immunology|March 1, 1996
Antigen-specific immunotherapy of autoimmune disease: a commentaryD C Wraith
Immunogenetics|January 1, 1984
Dk-restricted antiinfluenza cytotoxic T-cell clone loses one of its two alloreactivitiesD C Wraith
International Archives of Allergy and Immunology|December 1, 1995
Induction of antigen-specific unresponsiveness with synthetic peptides: specific immunotherapy for treatment of allergic and autoimmune conditionsD C Wraith
Research in Immunology|June 1, 1991
The use of MHC-binding peptides in the immunotherapy of autoimmune diseases: a commentaryD C Wraith
Immunology Today|October 8, 2014
The recognition of influenza A virus- infected cells by cytotoxic T lymphocytesD C Wraith
Immunology|August 14, 1999
Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functionsB Metzler, D C Wraith
Annals of the New York Academy of Sciences|February 13, 1996
Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitisB Metzler, D C Wraith
Therapeutic Immunology|February 1, 1995
Mucosal tolerance and the immunotherapy of autoimmune disease: a commentaryD C Wraith, B Metzler
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Immunology Series|January 1, 1993
Autoantigenic peptide therapy in experimental autoimmune encephalomyelitisD C Wraith
British Journal of Rheumatology|January 1, 1991
The use of class II MHC binding peptides in immunotherapyD C Wraith
Clinical and Experimental Immunology|March 1, 1996
Antigen-specific immunotherapy of autoimmune disease: a commentaryD C Wraith
Immunogenetics|January 1, 1984
Dk-restricted antiinfluenza cytotoxic T-cell clone loses one of its two alloreactivitiesD C Wraith
International Archives of Allergy and Immunology|December 1, 1995
Induction of antigen-specific unresponsiveness with synthetic peptides: specific immunotherapy for treatment of allergic and autoimmune conditionsD C Wraith
Research in Immunology|June 1, 1991
The use of MHC-binding peptides in the immunotherapy of autoimmune diseases: a commentaryD C Wraith
Immunology Today|October 8, 2014
The recognition of influenza A virus- infected cells by cytotoxic T lymphocytesD C Wraith
Immunology|August 14, 1999
Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functionsB Metzler, D C Wraith
Annals of the New York Academy of Sciences|February 13, 1996
Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitisB Metzler, D C Wraith
Therapeutic Immunology|February 1, 1995
Mucosal tolerance and the immunotherapy of autoimmune disease: a commentaryD C Wraith, B Metzler
Pageof 8